RemeGen Co., Ltd. (H-share listing on HKEX; A-share listing on SSE) reported no changes in either its authorised or issued share capital during October 2026, according to the company’s latest Monthly Return filed on 03 November 2026.
• Share Capital Structure – Authorised / registered share capital remained at 564.48 million shares, split between 208.58 million H shares and 355.90 million A shares, each with a par value of RMB 1. – There were no increases or reductions in either class during the month.
• Issued and Treasury Shares – H shares in issue stood unchanged at 208.58 million, with zero treasury shares outstanding. – A shares totalled 355.64 million in issue, alongside 0.25 million shares held as treasury; both figures were flat versus September.
• Public-Float Status RemeGen confirmed compliance with Hong Kong’s minimum public-float requirement for PRC issuers—at least 5 % of issued H shares—at month-end.
• Equity Incentive Schemes No new shares were issued and no treasury shares were transferred in October under the company’s equity incentive plans. Shares that may still be issued from approved schemes amount to 2.12 million A shares, comprising: – 2022 A Share Incentive Scheme (First Grant): 0.68 million shares available. – 2022 A Share Incentive Scheme (Reserved Grant): 0.36 million shares available. – 2023 A Share Incentive Scheme (First Grant): 1.08 million shares available.
RemeGen’s capital structure and share count therefore remained static through October 2026, while the company maintained regulatory compliance on public float levels.
Comments